Effect of NB-UVB combined with Creborol ointment in the treatment of non-segmentary vitiligo in stable stage

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500100175

Enrollment

Unknown

Registered

2025-04-03

Start date

2025-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

control group:Narrowband ultraviolet B irradiation

observation group:Narrowband ultraviolet B irradiation combined with topical crisaborole ointment

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients over 18 years of age with nonsegmental stable vitiligo;

Exclusion criteria

Exclusion criteria: 1.Patients with significant autoimmune diseases such as alopecia areata, diabetes, Addison's disease, thyroid disease, systemic lupus erythematosus, etc. And who are pregnant or breastfeeding or have a history of phototherapy, oral medication, or topical medication within the past 1 month.

Design outcomes

Primary

Measure	Time frame
VASI?effective rate, recurrence rate, incidence of adverse reactions;	—

Countries

China

Contacts

Public ContactGuangling Peng

The Fifth People Hospital of Chongqing

chris3371@126.com+86 23 6239 9812

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026